Document Detail


Pharmacokinetics of azlocillin in normal renal function: single and repetitive dosing studies.
MedLine Citation:
PMID:  6619035     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Systemic and urinary pharmacokinetic studies of the disposition of azlocillin were performed in seven male and six female healthy volunteers. Four separate studies identified the kinetics of the drug following a single 2, 3 or 4 g administration and during the repetitive administrations of 3 g of the drug over a five-day period. Peak plasma concentrations were 174 +/- 19 mg/l, 214 +/- 17 mg/l and 286 +/- 11 mg/l in the 2, 3 and 4 g single dose studies respectively. Trough values at 4 h post-dosing were 6 +/- 1 mg/l, 10 +/- 1 mg/l and 26 +/- 3 mg/l respectively. The plasma half-life of azlocillin was approximately 60 min. A dose-dependent phenomenon was observed. This was characterized by a slight but significant progressive increase in the plasma half-life of the drug as increasing amounts of drug were given and as the same amount was given repeatedly. No significant systemic accumulation of azlocillin was noted during the repetitive dosing study. The urinary excretion of the compound was prompt with most of the bioactive drug being eliminated in the first 4-6 h following dosing. The apparent volume of distribution of azlocillin was slightly greater than the extracellular fluid compartment. For the therapy of systemic infections in adults with normal renal function a 4 h or 6 h dosing cycle would be appropriate.
Authors:
F A Delgado; R L Stout; A Whelton
Related Documents :
11353635 - Pharmacokinetics and tissue penetration of linezolid following multiple oral doses.
10234595 - A comparison of the pharmacokinetics and tolerability of riluzole after repeat dose adm...
18035195 - Pharmacokinetic and pharmacodynamic properties of a single intravenous dose of ibutilid...
8405015 - Pharmacokinetic comparison of leucovorin and levoleucovorin.
21615815 - Oral vanoxerine prevents reinduction of atrial tachyarrhythmias: preliminary results.
11368955 - A selective cysteine protease inhibitor is non-toxic and cerebroprotective in rats unde...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Journal of antimicrobial chemotherapy     Volume:  11 Suppl B     ISSN:  0305-7453     ISO Abbreviation:  J. Antimicrob. Chemother.     Publication Date:  1983 May 
Date Detail:
Created Date:  1983-11-23     Completed Date:  1983-11-23     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  7513617     Medline TA:  J Antimicrob Chemother     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  79-88     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Azlocillin
Female
Half-Life
Humans
Kidney / physiology
Kinetics
Male
Penicillins / administration & dosage,  metabolism*,  urine
Time Factors
Chemical
Reg. No./Substance:
0/Penicillins; 37091-66-0/Azlocillin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Clinical experience with azlocillin.
Next Document:  Azlocillin kinetics during extracorporeal haemodialysis and peritoneal dialysis.